Chemomab Therapeutics Ltd banner

Chemomab Therapeutics Ltd
F:2QV0

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
F:2QV0
Watchlist
Price: 2.94 EUR Market Closed
Market Cap: €41.8m

Dividends

Chemomab Therapeutics Ltd
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Chemomab Therapeutics Ltd

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Chemomab Therapeutics Ltd

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

2QV0 Price
Chemomab Therapeutics Ltd

Annual Price Range
2.94
52w Low
2.94
52w High
3.92
Price Metrics
Average Annual Return -68.19%
Standard Deviation of Annual Returns 10.01%
Max Drawdown -97%
Shares Statistics
Market Capitalization 12.5m EUR
Shares Outstanding 14 219 000
Percentage of Shares Shorted
N/A

2QV0 Return Decomposition
Main factors of price return

Stock Splits

2QV0's latest stock split occurred on Aug 26, 2025

The company executed a 1-for-4 stock split, meaning that for every 4 shares held, investors received 1 new share.

Before the split, 2QV0 traded at 2.94 per share. Afterward, the share price was about 2.94.

The adjusted shares began trading on Aug 26, 2025. This was the only stock split in 2QV0's history.

Pre-Split Price
2.94 2.94
Post-Split Price
2.94
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett